Artemisinin combination therapy for vivax malaria
- 1 June 2010
- journal article
- review article
- Published by Elsevier BV in The Lancet Infectious Diseases
- Vol. 10 (6), 405-416
- https://doi.org/10.1016/s1473-3099(10)70079-7
Abstract
No abstract availableKeywords
This publication has 136 references indexed in Scilit:
- Artemisinin Resistance inPlasmodium falciparumMalariaNew England Journal of Medicine, 2009
- Artemisinin-based combination therapy for treating uncomplicated malariaCochrane Database of Systematic Reviews, 2009
- A Trial of Combination Antimalarial Therapies in Children from Papua New GuineaNew England Journal of Medicine, 2008
- Benefits of using multiple first-line therapies against malariaProceedings of the National Academy of Sciences of the United States of America, 2008
- Adverse Pregnancy Outcomes in an Area Where Multidrug‐ResistantPlasmodium vivaxandPlasmodium falciparumInfections Are EndemicClinical Infectious Diseases, 2008
- Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine–pyrimethamine in southern Papua, IndonesiaTransactions of the Royal Society of Tropical Medicine and Hygiene, 2007
- Dihydroartemisinin-Piperaquine versus Artesunate-Amodiaquine: Superior Efficacy and Posttreatment Prophylaxis against Multidrug-Resistant Plasmodium falciparum and Plasmodium vivax MalariaClinical Infectious Diseases, 2007
- Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparisonThe Lancet, 2007
- Lung Injury in Vivax Malaria: Pathophysiological Evidence for Pulmonary Vascular Sequestration and Posttreatment Alveolar‐Capillary InflammationThe Journal of Infectious Diseases, 2007
- Mapping the global extent of malaria in 2005Trends in Parasitology, 2006